Brandywine Global Investment Management’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $6.13M | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $8.09M | Sell |
|
|||||
|
2024
Q2 | $6.75M | Buy |
|
|||||
|
2024
Q1 | $5.92M | Buy |
|
|||||
|
2023
Q4 | $3M | Sell |
|
|||||
|
2023
Q3 | $2.54M | Buy |
|
|||||
|
2023
Q2 | $2.86M | Sell |
|
|||||
|
2023
Q1 | $3.54M | Hold |
|
|||||
|
2022
Q4 | $3.97M | Hold |
|
|||||
|
2022
Q3 | $2.74M | Sell |
|
|||||
|
2022
Q2 | $1.56M | Sell |
|
|||||
|
2022
Q1 | $2.11M | Hold |
|
|||||
|
2021
Q4 | $1.72M | Sell |
|
|||||
|
2021
Q3 | $1.86M | Buy |
|
|||||
|
2021
Q2 | $2.01M | Sell |
|
|||||
|
2021
Q1 | $1.63M | Sell |
|
|||||
|
2020
Q4 | $1.19M | Sell |
|
|||||
|
2020
Q3 | $1.34M | Buy |
|
|||||
|
2020
Q2 | $1.57M | Buy |
|
|||||
|
2020
Q1 | $1.3M | Buy |
|
|||||
|
2019
Q4 | $1.26M | Buy |
|
|||||
|
2019
Q3 | $1.5M | Sell |
|
|||||
|
2019
Q2 | $1.34M | Buy |
|
|||||
|
2019
Q1 | $1.09M | Buy |
|